Drug Type Small molecule drug |
Synonyms (±)-4-[1-hydroxy-2-(methylamino)ethyl]-o-phenylene divavalate, 1-(3',4'-dipivaloyloxyphenyl)-2-methylamino-1-ethanol, 4-[1-hydroxy-2-(methylamino)ethyl]-o-phenylene divavalate + [8] |
Target |
Mechanism adrenergic receptor agonists(Adrenergic receptors agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (02 May 1980), |
Regulation- |
Molecular FormulaC19H30ClNO5 |
InChIKeyVKFAUCPBMAGVRG-UHFFFAOYSA-N |
CAS Registry64019-93-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Dipivefrin Hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Ocular Hypertension | JP | 20 Sep 1988 | |
Glaucoma, Open-Angle | US | 02 May 1980 |
Phase 2 | 47 | (Placebo) | kfnugoenns(fcvqcnmtvw) = qqeitsdzhv eovcowlnkk (lrkaaempry, nmrhcmtdsv - tsteuoydpy) View more | - | 14 Aug 2019 | ||
(0.25 % Bupivacaine w/ Epinephrine & 4mg Dexamethasone) | kfnugoenns(fcvqcnmtvw) = dxrusayczk eovcowlnkk (lrkaaempry, dumxvzcenw - uwkbojyjuf) View more |